1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Huang, Q.
Yu, L.
Petros, A.M.
Gunasekera, A.
Liu, Z.
Xu, N.
Hajduk, P.
Mack, J.
Fesik, S.W.
Olejniczak, E.T.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Biochemistry
BICHAW
0033
0006-2960
43
6059
6063
10.1021/bi036155b
15147189
Structure of the N-Terminal RNA-Binding Domain of the SARS CoV Nucleocapsid Protein.
2004
10.2210/pdb1ssk/pdb
pdb_00001ssk
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
1
SINGLE WAVELENGTH
M
1
1.0
17179.035
Nucleocapsid protein
N-terminal Domain
1
man
polymer
N structural protein, NC
no
no
MGSSHHHHHHSSGLVPRGSAMGLPNNTASWFTALTQHGKEELRFPRGQGVPINTNSGPDDQIGYYRRATRRVRGGDGKMK
ELSPRWYFYYLGTGPEASLPYGANKEGIVWVATEGALNTPKDHIGTRNPNNNAATVLQLPQGTTLPKGFYAEGSRGGS
MGSSHHHHHHSSGLVPRGSAMGLPNNTASWFTALTQHGKEELRFPRGQGVPINTNSGPDDQIGYYRRATRRVRGGDGKMK
ELSPRWYFYYLGTGPEASLPYGANKEGIVWVATEGALNTPKDHIGTRNPNNNAATVLQLPQGTTLPKGFYAEGSRGGS
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
Coronavirus
SARS
Escherichia
Escherichia coli
sample
N
227859
SARS coronavirus
511693
Escherichia coli BL21
BL21
plasmid
pet21d+
database_2
pdbx_nmr_spectrometer
pdbx_struct_assembly
pdbx_struct_oper_list
struct_ref_seq_dif
repository
Initial release
Version format compliance
Version format compliance
Data collection
Database references
Derived calculations
1
0
2004-06-08
1
1
2008-04-29
1
2
2011-07-13
1
3
2022-03-02
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_nmr_spectrometer.model
_struct_ref_seq_dif.details
RCSB
Y
RCSB
2004-03-24
REL
1
3D_13C-separated_NOESY
3D_15N-separated_NOESY
100mM Nacl
6.8
ambient
298
K
simulated annealing
1
minimized average structure
0.5 mM N-terminal SARS CoV NP, U-15N,90% H2O/10% 2H2O, 50 mM sodium phosphate (pH 6.8) and 100 mM sodium chloride.
brunger
refinement
CNS
2000
800
Bruker
AVANCE
600
Bruker
AVANCE
500
Bruker
AVANCE
MET
1
n
1
MET
1
A
GLY
2
n
2
GLY
2
A
SER
3
n
3
SER
3
A
SER
4
n
4
SER
4
A
HIS
5
n
5
HIS
5
A
HIS
6
n
6
HIS
6
A
HIS
7
n
7
HIS
7
A
HIS
8
n
8
HIS
8
A
HIS
9
n
9
HIS
9
A
HIS
10
n
10
HIS
10
A
SER
11
n
11
SER
11
A
SER
12
n
12
SER
12
A
GLY
13
n
13
GLY
13
A
LEU
14
n
14
LEU
14
A
VAL
15
n
15
VAL
15
A
PRO
16
n
16
PRO
16
A
ARG
17
n
17
ARG
17
A
GLY
18
n
18
GLY
18
A
SER
19
n
19
SER
19
A
ALA
20
n
20
ALA
20
A
MET
21
n
21
MET
21
A
GLY
22
n
22
GLY
22
A
LEU
23
n
23
LEU
23
A
PRO
24
n
24
PRO
24
A
ASN
25
n
25
ASN
25
A
ASN
26
n
26
ASN
26
A
THR
27
n
27
THR
27
A
ALA
28
n
28
ALA
28
A
SER
29
n
29
SER
29
A
TRP
30
n
30
TRP
30
A
PHE
31
n
31
PHE
31
A
THR
32
n
32
THR
32
A
ALA
33
n
33
ALA
33
A
LEU
34
n
34
LEU
34
A
THR
35
n
35
THR
35
A
GLN
36
n
36
GLN
36
A
HIS
37
n
37
HIS
37
A
GLY
38
n
38
GLY
38
A
LYS
39
n
39
LYS
39
A
GLU
40
n
40
GLU
40
A
GLU
41
n
41
GLU
41
A
LEU
42
n
42
LEU
42
A
ARG
43
n
43
ARG
43
A
PHE
44
n
44
PHE
44
A
PRO
45
n
45
PRO
45
A
ARG
46
n
46
ARG
46
A
GLY
47
n
47
GLY
47
A
GLN
48
n
48
GLN
48
A
GLY
49
n
49
GLY
49
A
VAL
50
n
50
VAL
50
A
PRO
51
n
51
PRO
51
A
ILE
52
n
52
ILE
52
A
ASN
53
n
53
ASN
53
A
THR
54
n
54
THR
54
A
ASN
55
n
55
ASN
55
A
SER
56
n
56
SER
56
A
GLY
57
n
57
GLY
57
A
PRO
58
n
58
PRO
58
A
ASP
59
n
59
ASP
59
A
ASP
60
n
60
ASP
60
A
GLN
61
n
61
GLN
61
A
ILE
62
n
62
ILE
62
A
GLY
63
n
63
GLY
63
A
TYR
64
n
64
TYR
64
A
TYR
65
n
65
TYR
65
A
ARG
66
n
66
ARG
66
A
ARG
67
n
67
ARG
67
A
ALA
68
n
68
ALA
68
A
THR
69
n
69
THR
69
A
ARG
70
n
70
ARG
70
A
ARG
71
n
71
ARG
71
A
VAL
72
n
72
VAL
72
A
ARG
73
n
73
ARG
73
A
GLY
74
n
74
GLY
74
A
GLY
75
n
75
GLY
75
A
ASP
76
n
76
ASP
76
A
GLY
77
n
77
GLY
77
A
LYS
78
n
78
LYS
78
A
MET
79
n
79
MET
79
A
LYS
80
n
80
LYS
80
A
GLU
81
n
81
GLU
81
A
LEU
82
n
82
LEU
82
A
SER
83
n
83
SER
83
A
PRO
84
n
84
PRO
84
A
ARG
85
n
85
ARG
85
A
TRP
86
n
86
TRP
86
A
TYR
87
n
87
TYR
87
A
PHE
88
n
88
PHE
88
A
TYR
89
n
89
TYR
89
A
TYR
90
n
90
TYR
90
A
LEU
91
n
91
LEU
91
A
GLY
92
n
92
GLY
92
A
THR
93
n
93
THR
93
A
GLY
94
n
94
GLY
94
A
PRO
95
n
95
PRO
95
A
GLU
96
n
96
GLU
96
A
ALA
97
n
97
ALA
97
A
SER
98
n
98
SER
98
A
LEU
99
n
99
LEU
99
A
PRO
100
n
100
PRO
100
A
TYR
101
n
101
TYR
101
A
GLY
102
n
102
GLY
102
A
ALA
103
n
103
ALA
103
A
ASN
104
n
104
ASN
104
A
LYS
105
n
105
LYS
105
A
GLU
106
n
106
GLU
106
A
GLY
107
n
107
GLY
107
A
ILE
108
n
108
ILE
108
A
VAL
109
n
109
VAL
109
A
TRP
110
n
110
TRP
110
A
VAL
111
n
111
VAL
111
A
ALA
112
n
112
ALA
112
A
THR
113
n
113
THR
113
A
GLU
114
n
114
GLU
114
A
GLY
115
n
115
GLY
115
A
ALA
116
n
116
ALA
116
A
LEU
117
n
117
LEU
117
A
ASN
118
n
118
ASN
118
A
THR
119
n
119
THR
119
A
PRO
120
n
120
PRO
120
A
LYS
121
n
121
LYS
121
A
ASP
122
n
122
ASP
122
A
HIS
123
n
123
HIS
123
A
ILE
124
n
124
ILE
124
A
GLY
125
n
125
GLY
125
A
THR
126
n
126
THR
126
A
ARG
127
n
127
ARG
127
A
ASN
128
n
128
ASN
128
A
PRO
129
n
129
PRO
129
A
ASN
130
n
130
ASN
130
A
ASN
131
n
131
ASN
131
A
ASN
132
n
132
ASN
132
A
ALA
133
n
133
ALA
133
A
ALA
134
n
134
ALA
134
A
THR
135
n
135
THR
135
A
VAL
136
n
136
VAL
136
A
LEU
137
n
137
LEU
137
A
GLN
138
n
138
GLN
138
A
LEU
139
n
139
LEU
139
A
PRO
140
n
140
PRO
140
A
GLN
141
n
141
GLN
141
A
GLY
142
n
142
GLY
142
A
THR
143
n
143
THR
143
A
THR
144
n
144
THR
144
A
LEU
145
n
145
LEU
145
A
PRO
146
n
146
PRO
146
A
LYS
147
n
147
LYS
147
A
GLY
148
n
148
GLY
148
A
PHE
149
n
149
PHE
149
A
TYR
150
n
150
TYR
150
A
ALA
151
n
151
ALA
151
A
GLU
152
n
152
GLU
152
A
GLY
153
n
153
GLY
153
A
SER
154
n
154
SER
154
A
ARG
155
n
155
ARG
155
A
GLY
156
n
156
GLY
156
A
GLY
157
n
157
GLY
157
A
SER
158
n
158
SER
158
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
O
VAL
111
A
O
VAL
111
A
N
GLY
63
A
N
GLY
63
A
N
ALA
68
A
N
ALA
68
A
O
ARG
85
A
O
ARG
85
A
O
TRP
86
A
O
TRP
86
A
N
LEU
34
A
N
LEU
34
A
N
THR
35
A
N
THR
35
A
O
TYR
150
A
O
TYR
150
1
A
SER
4
49.54
94.31
1
A
HIS
7
-55.68
-176.69
1
A
HIS
8
-67.77
73.70
1
A
SER
11
73.72
40.45
1
A
ARG
17
57.96
105.27
1
A
MET
21
-59.42
-81.14
1
A
ASN
26
-142.32
36.07
1
A
SER
29
168.45
86.16
1
A
PHE
31
168.58
-179.91
1
A
ARG
43
171.74
76.78
1
A
PRO
45
-52.40
173.40
1
A
ARG
46
-64.10
-177.79
1
A
GLN
48
-136.09
-56.28
1
A
PRO
51
-48.64
177.75
1
A
ASN
53
63.08
179.13
1
A
ASN
55
-152.92
33.83
1
A
SER
56
-97.76
36.85
1
A
ASP
60
-150.55
54.14
1
A
ARG
67
-52.34
106.66
1
A
GLU
81
63.44
94.57
1
A
THR
93
-149.07
-54.09
1
A
PRO
95
-60.98
-149.74
1
A
ALA
97
47.08
29.02
1
A
LEU
99
-47.60
166.41
1
A
TYR
101
61.61
74.25
1
A
ALA
103
-64.66
80.24
1
A
GLU
114
-68.40
70.76
1
A
ASN
118
75.18
108.14
1
A
LYS
121
169.86
83.85
1
A
HIS
123
170.38
42.01
1
A
PRO
129
-59.08
78.45
1
A
ASN
130
167.45
-34.32
1
A
ASN
131
-73.79
-70.32
1
A
ALA
133
-61.48
-163.66
1
A
VAL
136
47.81
114.00
1
A
LEU
137
-43.18
167.67
1
A
GLN
138
-158.11
86.27
1
A
PRO
140
-59.39
-162.65
1
A
THR
144
-57.48
-164.65
1
A
PRO
146
-59.00
-147.88
1
A
LYS
147
-46.16
-86.71
1
A
ALA
151
-45.03
165.27
1
A
GLU
152
-35.75
-36.68
1
A
SER
154
50.38
77.22
minimized average
Structure of the N-terminal RNA-binding Domain of the SARS CoV Nucleocapsid Protein
1
N
N
STRUCTURAL PROTEIN
nucleocapsid protein, STRUCTURAL PROTEIN
NCAP_CVHSA
UNP
1
45
P59595
GLPNNTASWFTALTQHGKEELRFPRGQGVPINTNSGPDDQIGYYRRATRRVRGGDGKMKELSPRWYFYYLGTGPEASLPY
GANKEGIVWVATEGALNTPKDHIGTRNPNNNAATVLQLPQGTTLPKGFYAEGSRGGS
45
181
1SSK
22
158
P59595
A
1
22
158
1
cloning artifact
MET
1
1SSK
A
P59595
UNP
1
1
cloning artifact
GLY
2
1SSK
A
P59595
UNP
2
1
cloning artifact
SER
3
1SSK
A
P59595
UNP
3
1
cloning artifact
SER
4
1SSK
A
P59595
UNP
4
1
expression tag
HIS
5
1SSK
A
P59595
UNP
5
1
expression tag
HIS
6
1SSK
A
P59595
UNP
6
1
expression tag
HIS
7
1SSK
A
P59595
UNP
7
1
expression tag
HIS
8
1SSK
A
P59595
UNP
8
1
expression tag
HIS
9
1SSK
A
P59595
UNP
9
1
expression tag
HIS
10
1SSK
A
P59595
UNP
10
1
cloning artifact
SER
11
1SSK
A
P59595
UNP
11
1
cloning artifact
SER
12
1SSK
A
P59595
UNP
12
1
cloning artifact
GLY
13
1SSK
A
P59595
UNP
13
1
cloning artifact
LEU
14
1SSK
A
P59595
UNP
14
1
cloning artifact
VAL
15
1SSK
A
P59595
UNP
15
1
cloning artifact
PRO
16
1SSK
A
P59595
UNP
16
1
cloning artifact
ARG
17
1SSK
A
P59595
UNP
17
1
cloning artifact
GLY
18
1SSK
A
P59595
UNP
18
1
cloning artifact
SER
19
1SSK
A
P59595
UNP
19
1
cloning artifact
ALA
20
1SSK
A
P59595
UNP
20
1
initiating methionine
MET
21
1SSK
A
P59595
UNP
21
5
anti-parallel
anti-parallel
anti-parallel
anti-parallel
A
ILE
108
A
ILE
108
A
VAL
111
A
VAL
111
A
ILE
62
A
ILE
62
A
ALA
68
A
ALA
68
A
ARG
85
A
ARG
85
A
LEU
91
A
LEU
91
A
ALA
33
A
ALA
33
A
GLN
36
A
GLN
36
A
PHE
149
A
PHE
149
A
TYR
150
A
TYR
150